Significant Ownership of Apeiron Investment Group Ltd.

Signature - Title
/s/ Mario Frendo - Mario Frendo, Director
Location
Sliema, Malta
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Apeiron Investment Group Ltd..

Notify me when Apeiron Investment Group Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Apeiron Investment Group Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IGXT ATAI Life Sciences N.V. Ordinary Shares, par value Euro 0.10 per share 24% 56,551,379 +0.09% Christian Angermayer 16 Oct 2025
NEUP Neuphoria Therapeutics Inc. Common Stock 4.5% $376,887 72,618 Apeiron Investment Group Ltd. 24 Jan 2025

Schedules 13D/G Reported by Apeiron Investment Group Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.